Literature DB >> 30690298

Socioeconomic and geographic variations in the prevalence, awareness, treatment and control of dyslipidemia in middle-aged and older Chinese.

Peige Song1, Mingming Zha2, Xiangming Yang3, Yuehong Xu2, Hanyu Wang4, Zhe Fang3, Xiangrong Yang5, Wei Xia6, Chunxian Zeng7.   

Abstract

BACKGROUND AND AIMS: Unevenly socioeconomic development and nutrition transition might bring large variations in the epidemiology of dyslipidemia. We aimed to estimate the prevalence, awareness, treatment and control of dyslipidemia in different socioeconomic statuses and geographic regions in China, and to assess the associated factors and comorbidities of dyslipidemia.
METHODS: We included participants aged 45 years and above from a nationally representative investigation: the China Health and Retirement Longitudinal Study 2011. Dyslipidemia was defined based on the 2016 guideline of Chinese Prevention and Treatment of Dyslipidemia in adults. Multivariable logistic regression was adopted to assess the potentially associated factors and commodities of dyslipidemia.
RESULTS: In 2010, the prevalence of dyslipidemia was 42.84% among people aged 45 years and above. Low level of high-density lipoprotein cholesterol (HDL-C) was the most common type of dyslipidemia. The awareness, treatment and control rates among dyslipidemic subjects were 20.27%, 14.41% and 4.94%, respectively. In dyslipidemic patients who were under treatment, the control rate was 34.26%. People aged 50-59 years were at a significantly higher risk of dyslipidemia than those aged 45-49 years. Male gender, living in North China, overweight, obesity, central obesity, hypertension, diabetes and hyperuricemia were significantly associated with a higher risk of dyslipidemia. Current alcohol drinking and underweight were linked to a lower prevalence of dyslipidemia.
CONCLUSIONS: Our study revealed a high prevalence of dyslipidemia among middle-aged and older Chinese. The awareness, treatment and control rates were far from ideal and geographic inequality was highlighted. More efforts are needed to prevent and manage dyslipidemia in China.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Awareness; China; Control; Dyslipidemia; Prevalence; Treatment

Mesh:

Substances:

Year:  2019        PMID: 30690298     DOI: 10.1016/j.atherosclerosis.2019.01.005

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

1.  Self-Reported Sleep Characteristics Associated with Cardiovascular Disease Among Older Adults Living in Rural Eastern China: A Population-Based Study.

Authors:  Yu Qin; Rui Liu; Yongxiang Wang; Jiyou Tang; Lin Cong; Juan Ren; Shi Tang; Yifeng Du
Journal:  Clin Interv Aging       Date:  2022-05-18       Impact factor: 3.829

2.  Association Between Blood Heavy Metal Concentrations and Dyslipidemia in the Elderly.

Authors:  Xingmeng Zhu; Yong Fan; Jie Sheng; Ling Gu; Qi Tao; Rui Huang; Kaiyong Liu; Linsheng Yang; Guimei Chen; Hongjuan Cao; Kaichun Li; Fangbiao Tao; Sufang Wang
Journal:  Biol Trace Elem Res       Date:  2020-07-11       Impact factor: 3.738

3.  Awareness, treatment, control, and determinants of dyslipidemia among adults in China.

Authors:  Sampson Opoku; Yong Gan; Emmanuel Addo Yobo; David Tenkorang-Twum; Wei Yue; Zhihong Wang; Zuxun Lu
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

4.  Sex disparities in cardiovascular health metrics among rural-dwelling older adults in China: a population-based study.

Authors:  Xiaolei Han; Ziying Jiang; Yuanjing Li; Yongxiang Wang; Yajun Liang; Yi Dong; Shi Tang; Yifeng Du; Chengxuan Qiu
Journal:  BMC Geriatr       Date:  2021-03-04       Impact factor: 3.921

5.  The Niemann-Pick C1-like 1 rs2073547 polymorphism is associated with type 2 diabetes mellitus in a Chinese population.

Authors:  Zhenxing Huang; Ruyin Tan; Liheng Meng; Haiyan Yang; Xinghuan Liang; Yingfen Qin; Zuojie Luo
Journal:  J Int Med Res       Date:  2019-07-16       Impact factor: 1.671

6.  BMI, Blood Pressure, and Plasma Lipids among Centenarians and Their Offspring.

Authors:  Peng-Cheng Hai; Dong-Xiao Yao; Rui Zhao; Chen Dong; Sara Saymuah; Yue-Song Pan; Zhi-Feng Gu; Yi-Long Wang; Chen Wang; Jian-Lin Gao
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-20       Impact factor: 2.629

7.  Provincial heterogeneity in the management of care cascade for hypertension, diabetes, and dyslipidaemia in China: Analysis of nationally representative population-based survey.

Authors:  Yang Zhao; Kanya Anindya; Rifat Atun; Tiara Marthias; Chunlei Han; Barbara McPake; Nadila Duolikun; Emily Hulse; Xinyue Fang; Yimin Ding; Brian Oldenburg; John Tayu Lee
Journal:  Front Cardiovasc Med       Date:  2022-08-23

8.  Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP).

Authors:  Sampson Opoku; Yong Gan; Wenning Fu; Dajie Chen; Emmanuel Addo-Yobo; Diana Trofimovitch; Wei Yue; Feng Yan; Zhihong Wang; Zuxun Lu
Journal:  BMC Public Health       Date:  2019-11-11       Impact factor: 3.295

9.  The burden of stroke and modifiable risk factors in Ethiopia: A systemic review and meta-analysis.

Authors:  Teshager Weldegiorgis Abate; Balew Zeleke; Ashenafi Genanew; Bidiru Weldegiorgis Abate
Journal:  PLoS One       Date:  2021-11-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.